Decreased beta-amyloid and increased abnormal Tau deposition in the brain of aged patients with leprosy
- PMID: 7943169
- PMCID: PMC1887341
Decreased beta-amyloid and increased abnormal Tau deposition in the brain of aged patients with leprosy
Abstract
We examined the brains of 37 leprosy patients (mean age, 76.3 +/- 7.8 years), 5 patients with Alzheimer-type dementia (mean age, 79.0 +/- 9.5 years), and 23 age-matched non-dementia controls (mean age, 77.6 +/- 5.4 years). The frequency of beta-amyloid (A beta)-positive cases was lower (27.0%) in leprosy patients (n = 37) than in controls (47.8%; P = 0.05, Z = 1.49). When senile plaque subtypes were examined, type III (classical) plaques were significantly fewer (P < 0.05) in leprosy subjects compared with controls. Interestingly, neurofibrillary tangles in the temporal cortex were much more frequent in leprosy patients than in controls (P < 0.05). However, hippocampal CA3 pyramidal neurons in leprosy patients were well preserved. These data indicate that 1) leprosy patients have a low risk of A beta deposition but a high risk of abnormal tau deposition, 2) abnormal tau deposition is unrelated to A beta deposition in leprosy, and 3) neuronal loss is unrelated to abnormal tau deposition. It is not clear at present whether the result is related to the disease process itself, antileprosy treatment, environmental factors, or the genetic background in leprosy patients.
Similar articles
-
Alzheimer-type tau pathology in advanced aged nonhuman primate brains harboring substantial amyloid deposition.Brain Res. 2010 Feb 22;1315:137-49. doi: 10.1016/j.brainres.2009.12.005. Epub 2010 Jan 8. Brain Res. 2010. PMID: 20004650
-
Glial fibrillary acidic protein and beta A4 protein deposits in temporal lobe of aging brain and senile dementia of the Alzheimer type: relation with the cognitive state and with quantitative studies of senile plaques and neurofibrillary tangles.J Neurosci Res. 1990 Dec;27(4):587-94. doi: 10.1002/jnr.490270420. J Neurosci Res. 1990. PMID: 2079719
-
Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.Brain Res. 2008 Jun 5;1213:152-65. doi: 10.1016/j.brainres.2008.03.043. Epub 2008 Apr 1. Brain Res. 2008. PMID: 18455153
-
[Alzheimer's disease: lesions and their progression].Rev Neurol (Paris). 1999;155 Suppl 4:S17-27. Rev Neurol (Paris). 1999. PMID: 10637934 Review. French.
-
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.Science. 2002 Jul 19;297(5580):353-6. doi: 10.1126/science.1072994. Science. 2002. PMID: 12130773 Review.
Cited by
-
Warm, Sweetened Milk at the Twilight of Immunity - Alzheimer's Disease - Inflammaging, Insulin Resistance, M. paratuberculosis and Immunosenescence.Front Immunol. 2021 Aug 5;12:714179. doi: 10.3389/fimmu.2021.714179. eCollection 2021. Front Immunol. 2021. PMID: 34421917 Free PMC article. Review.
-
The Neuroprotective Effect of Doxycycline on Neurodegenerative Diseases.Neurotox Res. 2019 May;35(4):981-986. doi: 10.1007/s12640-019-00015-z. Epub 2019 Feb 23. Neurotox Res. 2019. PMID: 30798507 Review.
-
4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor.Int J Mol Sci. 2020 Aug 19;21(17):5953. doi: 10.3390/ijms21175953. Int J Mol Sci. 2020. PMID: 32824985 Free PMC article.
-
Therapeutic strategies for tauopathies and drug repurposing as a potential approach.Biochem Pharmacol. 2022 Apr;198:114979. doi: 10.1016/j.bcp.2022.114979. Epub 2022 Feb 24. Biochem Pharmacol. 2022. PMID: 35219701 Free PMC article. Review.
-
Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.Curr Protein Pept Sci. 2009 Oct;10(5):483-99. doi: 10.2174/138920309789351921. Curr Protein Pept Sci. 2009. PMID: 19538146 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous